Novel Immunotherapy Approaches for Glioblastoma

Novel Immunotherapy Approaches for Glioblastoma

Episodes

Specialty:

All

Year:

All

EP. 1: Challenges With Immunotherapy in Glioblastoma

March 5th 2018

EP. 2: Efficacy of Checkpoint Inhibition in Glioblastoma

March 5th 2018

EP. 3: DNA Vaccine Creating Immunogenicity in GBM

March 5th 2018

EP. 4: PD1 Inhibitor DNA Vaccine Combination Trial in GBM

March 5th 2018

EP. 5: GBM Rationale for Combining PD1 Inhibitor DNA Vaccine

March 5th 2018

EP. 6: GBM Emerging Strategies in Immunotherapy

March 5th 2018

EP. 7: Research Strategies to Improve Outcomes in GBM

March 5th 2018

Trending on OncLive

FDA Approves Tucatinib Plus Trastuzumab/Pertuzumab as First-Line Maintenance in Advanced HER2+ Breast Cancer

GI Cancer Monthly Rewind: Key News and Expert Insights You May Have Missed in September 2026

Five Under 5: Top Oncology Videos for the Week of 10/5/2026

FDA Grants Fast Track Designation to PSV359 for Advanced FAP-Positive Solitary Fibrous Tumors

Iberdomide Plus Daratumumab/Dexamethasone Yields Significant PFS Benefit in R/R Myeloma